Post

New research · Ophthalmology
Case reports in ophthalmological medicine · 2d
StudyCase reports in ophthalmological medicine · 2026

Suprachoroidal Triamcinolone Injection for the Management of Chronic Uveitis-Associated Ocular Hypotony.

Dan Spiegelman, Isabella Song, Erin Sieck
Read paper
OphthalmologyStudy

Suprachoroidal triamcinolone raised dangerously low eye pressure in one uveitis case.

Suprachoroidal Triamcinolone Injection for the Management of Chronic Uveitis-Associated Ocular Hypotony.

Dan Spiegelman … Erin Sieck
Case reports in ophthalmological medicine · 2026
Purpose

This study is aimed at describing the use of suprachoroidal triamcinolone injection for the treatment of refractory uveitis-associated ocular hypotony presumed secondary to ciliary body shutdown.

Methods

We report a case of a 58-year-old woman with a 26-year history of idiopathic, noninfectious bilateral panuveitis complicated by recurrent cystoid macular edema and a steroid-induced ocular hypertension.

Results
≥ 6 mmHg
Eye pressure rose from 2-6 mmHg to at least 6 mmHg for about 2 months after injection.
More results

Best corrected visual acuity improved from 20/80 to 20/50, and additional viscoelastic injections were not required during this period.

Numerical hypotony recurred 8 months later.

“
Conclusion · 1 of 2

Suprachoroidal triamcinolone may represent a targeted treatment for refractory uveitis-associated hypotony when ciliary body dysfunction is suspected and other steroid delivery routes are limited.

Conclusion · 2 of 2

Further study is needed to evaluate durability and broader applicability.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving